These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38191411)

  • 1. Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study.
    de Walque JM; de Terwangne C; Jungers R; Pierard S; Beauloye C; Laarbaui F; Dechamps M; Jacquet LM
    BMC Pulm Med; 2024 Jan; 24(1):19. PubMed ID: 38191411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal Carbon Dioxide Removal to De-escalate Venovenous Extracorporeal Membrane Oxygenation in Severe COVID-19 Acute Respiratory Distress Syndrome.
    Cambria G; Spelde AE; Olia SE; Biscotti M; Mackay E; Ibrahim M; Cevasco M; Bermudez C; Vernick W; Gutsche J; Usman AA
    J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):717-723. PubMed ID: 38212185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the safety and efficacy of the awake venovenous extracorporeal membrane oxygenation in patients with COVID-19-related ARDS.
    Sklienka P; Burša F; Frelich M; Máca J; Vodička V; Straková H; Bílená M; Romanová T; Tomášková H
    Ther Adv Respir Dis; 2024; 18():17534666241282590. PubMed ID: 39418135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venovenous extracorporeal membrane oxygenation after cardiac arrest for acute respiratory distress syndrome caused by Legionella: a case report.
    Grotberg JC; Schulte L; Schumer E; Sullivan M; Kotkar K; Masood MF; Pawale A
    J Cardiothorac Surg; 2024 Jan; 19(1):27. PubMed ID: 38281956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Survival of Prolonged Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: An Analysis of the Extracorporeal Life Support Organization Registry.
    Chandel A; Fabyan KD; Mendelsohn S; Puri N; Damuth E; Rackley CR; Conrad SA; King CS; Green A
    Crit Care Med; 2024 Jun; 52(6):869-877. PubMed ID: 38752812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
    Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
    Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA; Song T; Durham L; Garrison L; Smith D; Molnar Z; Scheier J; Deliargyris EN; Moazami N
    Crit Care; 2023 Jun; 27(1):243. PubMed ID: 37337243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prone position in patients with acute respiratory distress syndrome supported by venovenous extracorporeal membrane oxygenation: a retrospective cohort study.
    Chen Z; Li M; Gu S; Huang X; Xia J; Ye Q; Zheng J; Zhan Q; Wang C
    BMC Pulm Med; 2022 Jun; 22(1):234. PubMed ID: 35710365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.
    Tabatabai A; Ghneim MH; Kaczorowski DJ; Shah A; Dave S; Haase DJ; Vesselinov R; Deatrick KB; Rabin J; Rabinowitz RP; Galvagno S; O'Connor JV; Menaker J; Herr DL; Gammie JS; Scalea TM; Madathil RJ
    Ann Thorac Surg; 2021 Dec; 112(6):1983-1989. PubMed ID: 33485917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous extracorporeal membrane oxygenation: a systematic review.
    Li W; Chen Y; Li D; Meng X; Liu Z; Liu Y; Fan H
    Respir Res; 2024 Jan; 25(1):27. PubMed ID: 38217010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Extremely Prolonged (> 50 d) Venovenous Extracorporeal Membrane Oxygenation Support.
    Malas J; Chen Q; Shen T; Emerson D; Gunn T; Megna D; Catarino P; Nurok M; Bowdish M; Chikwe J; Cheng S; Ebinger J; Kumaresan A
    Crit Care Med; 2023 Jul; 51(7):e140-e144. PubMed ID: 36927927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma.
    Paternoster G; Bertini P; Belletti A; Landoni G; Gallotta S; Palumbo D; Isirdi A; Guarracino F
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2975-2982. PubMed ID: 35537972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Tracheostomy May Be Performed Safely in Obese COVID-19 Patients Supported on VV-ECMO.
    Tamargo IA; Creel-Bulos C; Callahan MC; Miller C; Dave SB; Parrilla GA; Chan JL; Daneshmand MA; Javidfar J
    Innovations (Phila); 2023; 18(5):472-478. PubMed ID: 37864489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adding the second drainage cannula in severely hypoxemic patients supported with VV ECMO due to COVID-19-associated ARDS.
    Szułdrzyński K; Kowalewski M; Jankowski M; Staromłyński J; Prokop J; Pasierski M; Chudziński K; Drobiński D; Martucci G; Lorusso R; Wierzba W; Zaczyński A; Król Z; Suwalski P
    Artif Organs; 2023 Oct; 47(10):1622-1631. PubMed ID: 37218216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical Therapy and Sedation While on Extracorporeal Membrane Oxygenation for COVID-19-Associated Acute Respiratory Distress Syndrome.
    Bohman JK; Nei SD; Mellon LN; Ashmun RS; Guru PK
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):524-528. PubMed ID: 34284915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal membrane oxygenation and COVID-19: The causes of failure.
    Ahmadi ZH; Jahangirifard A; Farzanegan B; Tabarsi P; Abtahian Z; Abedini A; Sharifi M; Jadbabaei AN; Mafhumi Y; Moslem A; Sistani M; Yousefian S; Saffaei A; Dastan F
    J Card Surg; 2020 Oct; 35(10):2838-2843. PubMed ID: 32678961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 outcomes of venovenous extracorporeal membrane oxygenation for acute respiratory failure vs historical cohort of non-COVID-19 viral infections.
    Dave SB; Rabinowitz R; Shah A; Tabatabai A; Galvagno SM; Mazzeffi MA; Rector R; Kaczorowski DJ; Scalea TM; Menaker J
    Perfusion; 2023 Sep; 38(6):1165-1173. PubMed ID: 35653427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center.
    Pieri M; Donatelli V; Calabrò MG; Scandroglio AM; Pappalardo F; Zangrillo A
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1703-1708. PubMed ID: 34686438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with COVID-19].
    Bakkehaug JP; Kåsine T; Romundstad L; Narum J; Laake JH; Svalebjørg M; Fiane AE; Hoel T; Thiara A; Pischke SE; Aasmundstad TA; Barratt-Due A
    Tidsskr Nor Laegeforen; 2023 Jan; 143(2):. PubMed ID: 36718886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venovenous extracorporeal membrane oxygenation support in patients with COVID-19 respiratory failure: A multicenter study.
    Vigneshwar NG; Masood MF; Vasic I; Krause M; Bartels K; Lucas MT; Bronsert M; Selzman CH; Thompson S; Rove JY; Reece TB; Cleveland JC; Pal JD; Fullerton DA; Aftab M
    JTCVS Open; 2022 Dec; 12():211-220. PubMed ID: 36097635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.